Affiliation:
1. Bristol Renal, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, U.K.
Abstract
Adiponectin has vascular anti-inflammatory and protective effects. Although adiponectin protects against the development of albuminuria, historically, the focus has been on podocyte protection within the glomerular filtration barrier (GFB). The first barrier to albumin in the GFB is the endothelial glycocalyx (eGlx), a surface gel-like barrier covering glomerular endothelial cells (GEnCs). In diabetes, eGlx dysfunction occurs before podocyte damage; hence, we hypothesized that adiponectin could protect from eGlx damage to prevent early vascular damage in diabetic kidney disease (DKD). Globular adiponectin (gAd) activated AMPK signaling in human GEnCs through AdipoR1. It significantly reduced eGlx shedding and the tumor necrosis factor-α (TNF-α)–mediated increase in syndecan-4 (SDC4) and MMP2 mRNA expression in GEnCs in vitro. It protected against increased TNF-α mRNA expression in glomeruli isolated from db/db mice and against expression of genes associated with glycocalyx shedding (namely, SDC4, MMP2, and MMP9). In addition, gAd protected against increased glomerular albumin permeability (Ps’alb) in glomeruli isolated from db/db mice when administered intraperitoneally and when applied directly to glomeruli (ex vivo). Ps’alb was inversely correlated with eGlx depth in vivo. In summary, adiponectin restored eGlx depth, which was correlated with improved glomerular barrier function, in diabetes.
Article Highlights
Funder
British Heart Foundation
Diabetes UK
David Telling Charitable Trust
Wellcome Trust Partnership Award Fellowship
MRC confidence in concepts
Biomarker Enterprise to Attack Diabetic Kidney Disease (BEAt-DKD) consortium
Kidney Research UK
Publisher
American Diabetes Association
Reference52 articles.
1. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999;Arita;Biochem Biophys Res Commun,2012
2. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients;Hotta;Arterioscler Thromb Vasc Biol,2000
3. A novel serum protein similar to C1q, produced exclusively in adipocytes;Scherer;J Biol Chem,1995
4. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism;Berg;Trends Endocrinol Metab,2002
5. Protective vascular and myocardial effects of adiponectin;Goldstein;Nat Clin Pract Cardiovasc Med,2009
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献